BTEFX
Price
$44.42
Change
+$0.46 (+1.05%)
Updated
Jun 6 closing price
Net Assets
243.48M
VTSMX
Price
$143.62
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

BTEFX vs VTSMX

Header iconBTEFX vs VTSMX Comparison
Open Charts BTEFX vs VTSMXBanner chart's image
Boston Trust Equity
Price$44.42
Change+$0.46 (+1.05%)
VolumeN/A
Net Assets243.48M
Vanguard Total Stock Mkt Idx I
Price$143.62
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
BTEFX vs VTSMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BTEFX vs. VTSMX commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BTEFX is a Buy and VTSMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 1.82T vs. BTEFX (243M). VTSMX pays higher dividends than BTEFX: VTSMX (1.18) vs BTEFX (0.73). BTEFX was incepted earlier than VTSMX: BTEFX (22 years) vs VTSMX (33 years). BTEFX (0.83) is less costly to investors than VTSMX (0.14). BTEFX is a more actively managed with annual turnover of: 3.22 vs. VTSMX (2.00). VTSMX has a lower initial minimum investment than BTEFX: VTSMX (3000) vs BTEFX (100000). VTSMX annual gain was more profitable for investors over the last year : 12.13 vs. BTEFX (5.55). VTSMX return over 5 years is better than : 82.86 vs. BTEFX (61.85).
BTEFXVTSMXBTEFX / VTSMX
Total Expense Ratio0.830.14593%
Annual Report Gross Expense Ratio0.830.14593%
Fund Existence22 years33 years-
Gain YTD0.1131.8886%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets243M1.82T0%
Annual Yield % from dividends0.731.1862%
Returns for 1 year5.5512.1346%
Returns for 3 years23.6541.8357%
Returns for 5 years61.8582.8675%
Returns for 10 years133.86182.9173%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMMT20.590.86
+4.36%
Summit Therapeutics
CNOB23.020.46
+2.04%
ConnectOne Bancorp
WOR60.220.91
+1.53%
Worthington Enterprises
ACU39.68N/A
N/A
Acme United Corp
CTXR0.85N/A
-0.56%
Citius Pharmaceuticals Inc